High-intensity focused ultrasound (HIFU)
The focus of the working group is the clinical use of therapeutic ultrasound, the innovative high-intensity focused ultrasound (HIFU), for treatment of various benign and malignant solid tumors. The main focus is on the HIFU treatment (1) of patients with inoperable pancreatic cancer for tumor mass reduction and relief of tumor-associated symptoms and (2) of patients with symptomatic uterine fibroids. The research group cooperates with international HIFU doctors from China, Spain, Bulgaria and Egypt.
HIFU-systems with ultrasound guidance
- HIFU JC TTS, Chongqing, China
- Theraclion Echopulse, France
- Mirabilis, USA
Indications
- Pancreatic cancer
- Uterine fibroids, adenomyosis
- Liver tumors (HCC, liver metastases)
- Bone tumors
- Breast tumors (fibroadenoma)
- Rare tumors e.g. desmoid tumors
- Thyroid nodes
Group Leader
PD Dr. med. Dr. rer. nat. Milka Marinova
E-Mail: Enable JavaScript to view protected content.
PD Dr. med. Claus C. Pieper
E-Mail: Enable JavaScript to view protected content.
Nurses
Frau Kathrin Bird
Frau Irene Zender
Tel.: +49 228-287 16464, 16413
E-Mail: Enable JavaScript to view protected content.